IBDEI20X ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,34333,1,4,0)
 ;;=4^G90.59
 ;;^UTILITY(U,$J,358.3,34333,2)
 ;;=^5004171
 ;;^UTILITY(U,$J,358.3,34334,0)
 ;;=G56.01^^131^1686^12
 ;;^UTILITY(U,$J,358.3,34334,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34334,1,3,0)
 ;;=3^Carpal Tunnel Syndrome,Right Upper Limb
 ;;^UTILITY(U,$J,358.3,34334,1,4,0)
 ;;=4^G56.01
 ;;^UTILITY(U,$J,358.3,34334,2)
 ;;=^5004018
 ;;^UTILITY(U,$J,358.3,34335,0)
 ;;=G56.02^^131^1686^11
 ;;^UTILITY(U,$J,358.3,34335,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34335,1,3,0)
 ;;=3^Carpal Tunnel Syndrome,Left Upper Limb
 ;;^UTILITY(U,$J,358.3,34335,1,4,0)
 ;;=4^G56.02
 ;;^UTILITY(U,$J,358.3,34335,2)
 ;;=^5004019
 ;;^UTILITY(U,$J,358.3,34336,0)
 ;;=G56.21^^131^1686^56
 ;;^UTILITY(U,$J,358.3,34336,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34336,1,3,0)
 ;;=3^Lesion of Ulnar Nerve,Right Upper Limb
 ;;^UTILITY(U,$J,358.3,34336,1,4,0)
 ;;=4^G56.21
 ;;^UTILITY(U,$J,358.3,34336,2)
 ;;=^5004024
 ;;^UTILITY(U,$J,358.3,34337,0)
 ;;=G56.22^^131^1686^55
 ;;^UTILITY(U,$J,358.3,34337,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34337,1,3,0)
 ;;=3^Lesion of Ulnar Nerve,Left Upper Limb
 ;;^UTILITY(U,$J,358.3,34337,1,4,0)
 ;;=4^G56.22
 ;;^UTILITY(U,$J,358.3,34337,2)
 ;;=^5004025
 ;;^UTILITY(U,$J,358.3,34338,0)
 ;;=M26.60^^131^1686^180
 ;;^UTILITY(U,$J,358.3,34338,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34338,1,3,0)
 ;;=3^Temporomandibular Joint Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,34338,1,4,0)
 ;;=4^M26.60
 ;;^UTILITY(U,$J,358.3,34338,2)
 ;;=^5011714
 ;;^UTILITY(U,$J,358.3,34339,0)
 ;;=L40.52^^131^1686^137
 ;;^UTILITY(U,$J,358.3,34339,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34339,1,3,0)
 ;;=3^Psoriatic Arthritis Mutilans
 ;;^UTILITY(U,$J,358.3,34339,1,4,0)
 ;;=4^L40.52
 ;;^UTILITY(U,$J,358.3,34339,2)
 ;;=^5009167
 ;;^UTILITY(U,$J,358.3,34340,0)
 ;;=L40.53^^131^1686^138
 ;;^UTILITY(U,$J,358.3,34340,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34340,1,3,0)
 ;;=3^Psoriatic Spondylitis
 ;;^UTILITY(U,$J,358.3,34340,1,4,0)
 ;;=4^L40.53
 ;;^UTILITY(U,$J,358.3,34340,2)
 ;;=^5009168
 ;;^UTILITY(U,$J,358.3,34341,0)
 ;;=M32.9^^131^1686^179
 ;;^UTILITY(U,$J,358.3,34341,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34341,1,3,0)
 ;;=3^Systemic Lupus Erythematosus,Unspec
 ;;^UTILITY(U,$J,358.3,34341,1,4,0)
 ;;=4^M32.9
 ;;^UTILITY(U,$J,358.3,34341,2)
 ;;=^5011761
 ;;^UTILITY(U,$J,358.3,34342,0)
 ;;=M32.0^^131^1686^175
 ;;^UTILITY(U,$J,358.3,34342,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34342,1,3,0)
 ;;=3^Systemic Lupus Erythematosus,Drug-Induced
 ;;^UTILITY(U,$J,358.3,34342,1,4,0)
 ;;=4^M32.0
 ;;^UTILITY(U,$J,358.3,34342,2)
 ;;=^5011752
 ;;^UTILITY(U,$J,358.3,34343,0)
 ;;=M32.13^^131^1686^177
 ;;^UTILITY(U,$J,358.3,34343,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34343,1,3,0)
 ;;=3^Systemic Lupus Erythematosus,Lung Involvement
 ;;^UTILITY(U,$J,358.3,34343,1,4,0)
 ;;=4^M32.13
 ;;^UTILITY(U,$J,358.3,34343,2)
 ;;=^5011756
 ;;^UTILITY(U,$J,358.3,34344,0)
 ;;=M32.14^^131^1686^176
 ;;^UTILITY(U,$J,358.3,34344,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34344,1,3,0)
 ;;=3^Systemic Lupus Erythematosus,Glomerular Disease
 ;;^UTILITY(U,$J,358.3,34344,1,4,0)
 ;;=4^M32.14
 ;;^UTILITY(U,$J,358.3,34344,2)
 ;;=^5011757
 ;;^UTILITY(U,$J,358.3,34345,0)
 ;;=M32.12^^131^1686^178
 ;;^UTILITY(U,$J,358.3,34345,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34345,1,3,0)
 ;;=3^Systemic Lupus Erythematosus,Pericarditis
 ;;^UTILITY(U,$J,358.3,34345,1,4,0)
 ;;=4^M32.12
 ;;^UTILITY(U,$J,358.3,34345,2)
 ;;=^5011755
 ;;^UTILITY(U,$J,358.3,34346,0)
 ;;=M05.59^^131^1686^159
 ;;^UTILITY(U,$J,358.3,34346,1,0)
 ;;=^358.31IA^4^2
